WIN-Partners Co., Ltd. (TYO:3183)

Market Cap	42.23B
Revenue (ttm)	82.61B
Net Income (ttm)	2.05B
Shares Out	28.86M
EPS (ttm)	71.56
PE Ratio	20.44
Forward PE	n/a
Dividend	51.00 (3.26%)
Ex-Dividend Date	Mar 28, 2025

Volume	103,400
Average Volume	81,955
Open	1,524.00
Previous Close	1,519.00
Day's Range	1,515.00 - 1,568.00
52-Week Range	1,012.00 - 1,568.00
Beta	0.08
RSI	64.13
Earnings Date	May 15, 2025

About WIN-Partners

WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices to medical institutions primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and embolic ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1973
• Employees: 629
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 3183

Financial Performance

In 2023, WIN-Partners's revenue was 77.06 billion, an increase of 8.76% compared to the previous year's 70.85 billion. Earnings were 1.84 billion, a decrease of -10.36%.